ApoC3 Inhibitors Show Efficacy in Lowering Triglycerides and Reducing Cardiovascular ...
ApoC3 Inhibitors Show Efficacy in Lowering Triglycerides and Reducing Cardiovascular Risks at NLA 2025 Conference ... AI . Source: GO- AI -ne1. Date: May ...
Read the original at GeneOnline ↗
- Tracked via
- “AI Risks”